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OBJECTIVE: To assess the incidence of intra-operative immediate hypersensitivity reactions and anaphylaxis.
METHODS: A cross-sectional observational study was conducted at the Department of Anesthesiology,
University of Sa˜o Paulo School of Medicine, Hospital das Clı´nicas, Sa˜o Paulo, Brazil, from January to December
2010. We developed a specific questionnaire to be completed by anesthesiologists. This tool included questions
about hypersensitivity reactions during anesthesia and provided treatments. We included patients with clinical
signs compatible with immediate hypersensitivity reactions. Hhypersensitivity reactions were categorized
according to severity (grades I-V). American Society of Anesthesiologists physical status classification (ASA 1-6)
was analyzed and associated with the severity of hypersensitivity reactions.
RESULTS: In 2010, 21,464 surgeries were performed under general anesthesia. Anesthesiologists answered ques-
tionnaires on 5,414 procedures (25.2%). Sixty cases of intra-operative hypersensitivity reactions were reported.
The majority patients (45, 75%) had hypersensitivity reactions grade I reactions (incidence of 27.9:10,000).
Fifteen patients (25%) had grade II, III or IV reactions (intra-operative anaphylaxis) (incidence of 7:10,000). No
patients had grade V reactions. Thirty patients (50%) were classified as ASA 1. The frequency of cardiovascular
shock was higher in patients classified as ASA 3 than in patients classified as ASA 1 or ASA 2. Epinephrine was
administered in 20% of patients with grade III hypersensitivity reactions and in 50% of patients with grade II
hypersensitivity reactions.
CONCLUSIONS: The majority of patients had hypersensitivity reactions grade I reactions; however, the incidence
of intra-operative anaphylaxis was higher than that previously reported in the literature. Patients with ASA 3
had more severe anaphylaxis; however, the use of epinephrine was not prescribed in all of these cases. Allergists
and anesthesiologists should implement preventive measures to reduce the occurrence of anaphylaxis.
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’ INTRODUCTION
According to the International Consensus (ICON) on
Drug Allergy, hypersensitivity reactions (HSR) to drugs
are adverse drug effects that clinically resemble allergic
reactions. These reactions are classified as immediate or non-
immediate (delayed) according to their onset during treat-
ment (1). Immediate HSRs typically occur within 1 hour after
last drug intake and include signs and symptoms such as
urticaria, angioedema, rhinitis, conjunctivitis, bronchospasm,
gastrointestinal symptoms (nausea, vomiting, diarrhea, or
abdominal pain) and anaphylaxis (1). On the other hand,
the ICON on Anaphylaxis defined anaphylaxis as a serious,
generalized or systemic HSR that can be life-threatening
or fatal (2). In general, anaphylactic reactions are defined
as immediate HSRs that compromise two or more organs
or systems.
In anesthesia, intra-operative anaphylaxis is a rare yet
troublesome complication that can disrupt the surgical
procedure and can ultimately be fatal (3-5). However, the
incidence of milder, immediate HSRs and anaphylaxis during
anesthesia remains unknown mainly because cases are not
systematically reported in most countries. The incidence
of intra-operative anaphylaxis can be reduced by prevent-
ing these reactions in patients with a history of previous
reactions during surgical procedures (6). Early identification
of the symptoms and signs of a reaction can prevent severe
anaphylaxis.
In France, cases of intra-operative anaphylaxis have been
reported since 1985, enabling an understanding of these
reactions and the implementation of effective interventions
to prevent them (6,7). After eight years of monitoring theseDOI: 10.6061/clinics/2018/e287
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cases, the incidence of intra-operative immediate HSR was
estimated to range from 0.5 to 2.9:10,000 (6-8). Worldwide,
intra-operative systemic reactions account for 9-19% of
all surgical complications and 5-7% of all deaths during
anesthesia (7). Neuromuscular blocking agents (NMBAs)
continue to be the main etiological agents (implicated in
58.08% of cases) and are followed by latex (in 19.65%) and
antibiotics (in 12.85%) (8).
Analysis of anesthetic records provides essential informa-
tion about intra-operative HSR, such as clinical manifesta-
tions, drugs that might be involved, and timing between
the drug infusion and the onset of a reaction (5). Studies
addressing intra-operative immediate HSR are important
and can help prevent further adverse reactions. The aim of
this study was to evaluate the incidence and profiles of intra-
operative immediate systemic HSR and analyze potentially
associated factors.
In this study, allergists developed a questionnaire, which
was answered by anesthesiologists just after surgical pro-
cedures during the year 2010. With this new tool, we found a
high incidence of immediate hypersensitivity reactions, from
mild cutaneous reactions to anaphylaxis (7:10.000 anesthesias).
This simple questionnaire can increase diagnosis of perio-
perative hyper- sensitivity reactions.
’ MATERIALS AND METHODS
This cross-sectional observational study was conducted
using data provided by anesthesiologists through a voluntary-
encouraged reporting system. Allergists with expertise
in drug hypersensitivity, together with anesthesiologists,
developed a specific questionnaire to assess the occurrence
of systemic HSR during intra-operative periods (Figure 1).
The questionnaire was attached to all medical records related
to the anesthesia applied during surgical procedures perfor-
med from January to December 2010 at Hospital das Clı´nicas,
São Paulo, Brazil. Anesthesiologists were encouraged to
complete the questionnaire at the end of each surgical
procedure whether or not intra-operative reactions occurred.
Cases of intra-operative immediate HSR were selected for
analysis. In addition to the data provided by the anesthesiol-
ogists on the questionnaires, we analyzed data obtained from
the medical records, such as gender, age, types of surgical
procedures associated with the reported HSR, and the
American Society of Anesthesiologists (ASA) physical
status classification (ASA 1-6) was used as an indicator of
physical status (9).
Symptoms and signs reported by anesthesiologists
in the questionnaire were assessed. We considered the
following symptoms and signs to be compatible with
immediate reactions: angioedema, urticaria, cutaneous
rash, bronchospasm, dyspnea, decreased oxygen saturation,
cyanosis, tachycardia, bradycardia, mild hypotension, cardio-
vascular shock, cardiorespiratory arrest, vomiting, nausea
and diarrhea.
The severity of systemic reactions was classified in five
stages of increasing severity according to international
guidelines (7,10): grade I (generalized cutaneous signs:
erythema, urticaria with or without angioedema), grade II
(moderate multi-organ involvement with cutaneous signs,
hypotension and severe tachycardia, bronchial hyperreactiv-
ity), grade III (severe life-threatening multi-organ involve-
ment that requires specific treatment: collapse, tachycardia or
bradycardia, cardiac arrhythmias, bronchospasm; cutaneous
signs may be absent or occur only after arterial blood pres-
sure recovers a normal value), grade IV (circulatory and/or
Figure 1 - Specific questionnaire to identify intra-operative immediate hypersensitivity reactions.
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respiratory arrest) or grade V (death due to inefficient cardio-
respiratory resuscitation).
Provided treatments were also evaluated with special
attention to the use of epinephrine.
We assessed drugs or materials mentioned by anesthe-
siologists as possible causative agents (NMBAs, opioids,
antibiotics, non-steroidal anti-inflammatory drugs, local
anesthetics, immunosuppressants, packed platelets, and
other substances, such as latex, iodine solution and chlor-
hexidine), and we associated them with the severity of
reactions.
Ethics
This study was approved by the Research Ethics Commit-
tee of the University of São Paulo, School of Medicine,
located in the city of São Paulo, Brazil (protocol number
CAPPesq 0791/10).
Statistical analysis
Categorical variables were compared using Fisher’s exact
test, and po0.05 was considered statistically significant.
’ RESULTS
During the study period (from January to December 2010),
21,464 surgical or diagnostic-therapeutic procedures were
performed under general anesthesia. Anesthesiologists
answered questionnaires on 5,414 procedures (25.2% of
all procedures during the study period), and 60 cases of
intra-operative immediate HSR were reported, as shown in
Figure 2. If we assume that unanswered questionnaires
represent the absence of systemic HSR, the incidence of
HSR was 27.9:10,000.
We evaluated the 60 patients diagnosed with intra-
operative systemic reactions, 34 (56.7%) of whom were
female, and their mean age was 36.7 (±19.3) years. Non-
vascular abdominal procedures, followed by plastic surgery
and ophthalmological surgery, were the most commonly
cited types of surgical procedures associated with systemic
reactions (Table 1). Thirty patients (50%) had ASA physical
status class 1, 20 patients (33.4%) had ASA 2 and 10 patients
(16.7%) had ASA 3.
Figure 2 - Case selection algorithm based on questionnaires answered by anesthesiologists about the occurrence of systemic
hypersensitivity reactions (HSR) during intra-operative period in procedures performed from January to December 2010. HSR,
hypersensitivity reactions.
Table 1 - Types of surgical procedures during which
intra-operative immediate hypersensitivity reactions occurred.
Type of procedure n (%)
Non-vascular abdominal surgery 13 (21.7)
Plastic surgery 10 (16.7)
Ophthalmological surgery 10 (16.7)
Urological surgery 9 (15)
Otorhinolaryngological surgery 6 (10)
Gynecological/obstetric surgery 5 (8.3)
Neurosurgery 2 (3.4)
Thoracic surgery 1 (1.7)
Vascular surgery 1 (1.7)
Orthopedic surgery 1 (1.7)
Double surgical procedures 2 (3.4)
Total 60 (100)
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Skin manifestations were the most commonly reported
signs and symptoms, occurring in 57 (95%) patients, and
they were mainly described as rashes. We found that 45/
60 patients (75%) presented only cutaneous signs and were
classified as grade I reactions according to international
guidelines (5,8). The remaining 15 patients (25%) presented
grade II (16.7%) and III (8.3%) systemic immediate HSR,
which were considered anaphylactic reactions. No cardiac or
respiratory arrests and no deaths were reported (grade IV
and V, respectively). Then, we found an incidence of 7:10,000
for intra-operative anaphylaxis. The clinical features observed
in all 60 intra-operative immediate HSR are described in
Table 2. The frequency of cardiovascular shock was higher in
patients with ASA physical status 3 than in those classified
with ASA 1 or 2 (Figure 3).
Epinephrine was administered in 6 (50%) patients with
grade II reactions and in 1 (20%) individual with a grade III
reaction (p40.05). Epinephrine was not used in all cases with
compromised cardiorespiratory function. Two (50%) of the
remaining 4 patients who presented grade III reactions were
treated with other vasopressors. One patient was treated
with a continuous infusion of intravenous norepinephrine and
the other received metaraminol and terlipressin. No patients
with cutaneous isolated signs (grade I reactions) were treated
with epinephrine.
The drugs most often judged to be the culprit agent of
the systemic reaction were NMBAs, which were implicated
in 36.7% of patients, followed by hypnotics in 26.7%.
Anesthesiologists did not report a culprit agent in 30%
of the 60 cases (Figure 4). There was no difference between
agents suspected by anesthesiologists and the severity of
reactions (Table 3).
’ DISCUSSION
Within our study sample, the incidence of intra-operative
anaphylaxis was 7 cases per 10,000 and the incidence
of systemic immediate HSR, including isolated cutaneous
reactions, was 27.9:10,000. This incidence of intra-operative
anaphylaxis was higher than what has been reported in the
literature (6-8). The incidence of intra-operative allergic and
non-allergic anaphylactic reactions varies among countries
and centers and across studies, depending on the applied
methodology. In a recently published study from the Cleveland
Clinic, approximately 15:10,000 immediate HSR were found
during non-cardiac surgeries (11). They used a novel electronic
search protocol developed to identify potential reactions
that included the administration of epinephrine, antihista-
mines and blood tests, such as immunoglobulin E (IgE) and
tryptase (11).
The use of a specific questionnaire aimed at anesthesiol-
ogists (even though its use was voluntarily) might have
stimulated reporting and could therefore explain the rela-
tively high incidence observed in this study. Milder cases
were reported (grade I reactions) in the questionnaire that
might not have been reported in regular conditions. The
frequency of answered questionnaires was low (25.2%).
We believe that unanswered questionnaires corresponded
to surgeries with no adverse reactions. On the other hand,
if we evaluated only answered questionnaires, our incidence
of HSRs would be much higher and would have possibly
made our data unreliable.
We did not find a large difference in the incidence of
HSRs between genders. It has been postulated that sexual
hormones are responsible for the fact that in adults, the
incidence of intra-operative anaphylaxis is higher in women
Table 2 - Clinical manifestations of intra-operative
hypersensitivity reactions.
System Clinical sign(s) n (%)
Cutaneous Rash 45 (75)
Urticaria 7 (11.7)
Rash and urticaria 5 (8.3)
Angioedema 2 (3.3)
Itching 2 (3.3)
Respiratory Bronchospasm, dyspnea,
decreased oxygen saturation
4 (6.7)
Cardiovascular Tachycardia 4 (6.6)
Bradycardia 6 (10)
Mild hypotension 6 (10)
Cardiovascular shock 5 (8.3)
Gastrointestinal Vomiting, nausea, diarrhea 1 (1.7)
Figure 3 - Hypersensitivity reaction grade of severity according to ASA physical status (n=60). HSR, hypersensitivity reactions.
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than in men, given that the incidence is similar between both
genders before puberty (8). We did not evaluate children in
this group of patients because the study was conducted at an
adult university hospital; females accounted for approxi-
mately half of the study sample.
The most common surgical procedures in the 60 evaluated
cases were non-vascular abdominal surgeries. This result
might be related to the fact that these surgeries last longer
than others, resulting in longer anesthesia times and higher
doses of the employed drugs, and longer exposure times
to latex for the mucous membranes. Moreover, half of the
evaluated cases were ASA 1 physical status. At our hospital,
the majority of surgeries are non-urgent and occur when the
patient is clinically stable.
Skin reactions constituted the most common clinical
manifestation of intra-operative reactions. In a study
conducted in France involving 2,516 patients with intra-
operative anaphylaxis, skin symptoms were found to be
more common in cases of non-IgE-mediated anaphylaxis
than in those of IgE-mediated anaphylaxis (in 95.3% vs.
70.2%) (8). Therefore, there can be cases of intra-operative
anaphylaxis in which no skin reaction exists or in which
the reaction is discreet and goes undiagnosed when it
occurs in isolation. Consequently, it is extremely important
that anesthesiologists pay careful attention to patient skin
conditions because surgical drapes can obscure these visible
signs. It is important to diagnose patients with milder
reactions because these diagnoses might prevent more severe
reactions. Despite the relatively high incidence of intra-
operative anaphylaxis observed in the present study, no
deaths were reported in 2010.
After the patients had been classified by ASA physical
status and systemic immediate HSR severity, we identified
an association between these two factors. We found no
cardiovascular shock in patients with an ASA physical status
of 1. Grade III reactions were mainly present in patients with
ASA 3, showing that a higher frequency of comorbidities
worsens the severity of anaphylaxis. In addition to treatment
with beta-blockers or angiotensin-converting enzyme inhibi-
tors, some comorbidities, such as uncontrolled asthma and
severe cardiovascular disease, are associated with a higher
risk of intra-operative anaphylaxis (10). Other risk factors
for intra-operative immediate reactions have already been
cited in the literature, such as a history of adverse reactions
to anesthetics in previous surgeries, symptoms suggestive
of latex allergy or allergy to fruits (possible cross-reactivity
with latex) and children undergoing multiple surgeries.
There is no evidence of increased risk in patients with atopy
or allergy to drugs not used in anesthesia (7).
Based on the severity of the reactions, we assessed the use
of epinephrine, indicated as the first-choice treatment when
anaphylaxis appears, to impair cardiopulmonary function (12,13).
In the present study, epinephrine was used in 7 patients
(6 patients with grade II reactions and 1 patient with a
grade III reaction). However, epinephrine was not used
in the remaining 4 cases of grade III reactions; a lack of
epinephrine is associated with a poor prognosis. Half of
these patients were treated with other vasopressors, but the
literature contains limited data on their use for anaphylaxis
treatment. Late administration of epinephrine has been
Table 3 - Possible causative agents according to reaction
grade severity.
Drugs Grade I Grade II Grade III
n (%) n (%) n (%)
NMBAs 16 (26.7) 4 (6.6) 2 (3.3)
Hypnotics 14 (23.3) 1 (1.7) 1 (1.7)
Antibiotics 2 (3.3) 3 (5) 0 (0)
Opioids 3 (5) 0 (0) 0 (0)
Latex 1 (1.7) 1 (1.7) 1 (1.7)
NSAIDs 1 (1.7) 0 (0) 0 (0)
Other 2 (3.3) 0 (0) 3 (5)
Not answered 11 (18.3) 6 (10) 1 (1.7)
NMBAs: Neuromuscular blocking agents, NSAIDs: Non-steroidal
anti-inflammatory drugs.
p40.05 (Fisher’s exact test).
Figure 4 - Possible causative agents of reaction as determined by anesthesiologists on the basis of identified clinical signs (n=60).
NMBAS: Neuromuscular blocking agents, NSAIDS: Non-steroidal anti-inflammatory drugs.
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demonstrated as the main factor associated with death
from anaphylaxis (14). We believe that anesthesiologists can
misdiagnose anaphylaxis as hypotension during surgery, as
these HSRs are uncommon, whereas there are many other
causes of hypotension under anesthesia. These physicians
probably need to be better trained in the management of
anaphylactic reactions because diagnosis leads to treatment.
The surveyed anesthesiologists indicated which agent they
suspected as the cause of the reaction. Therefore, the data
related to the main groups of possible causative agents in this
study refer to clinical assessments of the involved anesthe-
siologists. In agreement with other samples described in
the literature (3,5,7,15), NMBAs were the most common
agents implicated by the anesthesiologists. Nevertheless,
after NMBAs, the second principal agents involved in HSRs
were hypnotics; in contrast, other studies reported latex
(3,5,7,15). In United States, antibiotics are the primary cause
of intra-operative anaphylaxis (16). As the causative agents
were defined by the clinical judgment of anesthesiologists,
it is possible that these data might not be corroborated
by in vivo and in vitro tests. Additional studies are needed
to establish the main causative agents. In five cases, the
clinical observations of anesthesiologists noted other pos-
sible causes of intra-operative reactions: local anesthetic,
immunosuppressants, packed platelets, iodine solution and
adhesive plaster.
We did not find any difference between agents implicated
by the clinical judgment of anesthesiologists and the severity
of the clinical manifestations. Another study showed that
intra-operative anaphylaxis caused by NMBAs or antibiotics
were more severe than those caused by latex (17). The
authors demonstrated that the clinical variability of the
reactions was also related to the involved pathophysiolog-
ical mechanism. In that study, cardiovascular collapse and
bronchospasm were found to be more common among
patients with IgE-mediated HSR than among those with non-
IgE-mediated HSR with the latter mainly developing skin
symptoms (17). We recently demonstrated that drug-induced
anaphylaxis was more severe than IgE-mediated anaphylaxis
and that these results were independent of whether they
were related to surgical procedures or not (18). We believe
that the small number of reactions in our study made it
difficult to show differences in the severity of reactions accord-
ing to suspected drugs. Furthermore, only some of these
patients were subjected to allergy investigation after their
reaction (data not shown).
Reporting of intra-operative immediate HSR cases is
important because it allows at-risk patients to be identified,
thereby potentially preventing fatal reactions and increasing
knowledge of the most common causative agents. Prevention
measures, such as opting to use drugs that are less related to
immediate HSR and early diagnosis of latex allergy, can be
established through compulsory reporting and examinations
of reported cases. Both approaches would reduce the number
of cases of intra-operative anaphylaxis. In addition, the
possibility of intra-operative reactions should considered
when assessing the risk-benefit ratio of various anesthetic
techniques (8).
The main limitation of the present study is that the clinical
data and diagnoses were based on assessments made by
anesthesiologists, who may not be used to these signs,
particularly cutaneous reactions. Moreover, they did not
have access to serum tryptase measurements, which are an
important diagnostic test for systemic reactions.
Collaboration between anesthesiologists and allergists is
essential for guiding investigations conducted by the latter
(7). Mild reactions (grade I) were reported in this study,
which could help patients and physicians investigate their
cause to avoid anaphylactic reactions in future procedures.
Once the investigation has been conducted, patients with a
history of intra-operative immediate systemic reaction can be
advised regarding future exposure, thus reducing the risk of
subsequent anaphylactic reactions (19).
In conclusion, the incidence of intra-operative anaphy-
laxis observed in the present study was higher than pre-
viously reported incidences in other countries. This result
should prompt allergists and anesthesiologists to establish
systematic reporting of cases of intra-operative immediate
reactions and implement preventive measures to reduce
its occurrence.
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